Entasis Therapeutics Holdings Headquarters
Looking for information about Entasis Therapeutics Holdings Headquarters? The links below have collected all the necessary data.
Entasis Therapeutics Precision Antibacterial Therapies
- https://www.entasistx.com/
- Entasis Therapeutics strives towards global advancement by addressing the critical threat of multi-drug resistant bacteria. We have assembled a world-class team with a global calling to work on these life-saving, long lasting antibacterial therapies.
Investor FAQs Entasis Therapeutics Holdings Inc.
- https://investors.entasistx.com/investor-resources/investor-faqs
- Entasis Therapeutics Holdings Inc. completed its initial public offering on September 25, 2018 at a price of $15.00.
Corporate Profile Entasis Therapeutics Holdings Inc.
- https://investors.entasistx.com/corporate-profile
- Entasis Therapeutics was established in 2015 as a spin-out from and with initial funding from AstraZeneca, and all rights to AstraZeneca’s industry-leading discovery and early development small-molecule anti-infectives portfolio. Since receiving our funding from AstraZeneca, we have raised $81.9 million in gross proceeds from equity ...
Contact Entasis Therapeutics
- https://www.entasistx.com/contact
- Contact Entasis with comments or questions. Want to receive periodic news about Entasis’ progress? Subscribe to our news wire by filling out the confidential sign-up form.
Entasis Therapeutics Completes Initial Closing of $35M ...
- https://investors.entasistx.com/news-releases/news-release-details/entasis-therapeutics-completes-initial-closing-35m-private
- WALTHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that it has completed the initial $3.3 million closing of a $35 million common stock and warrant securities investment with Innoviva Inc. (NASDAQ ...
Pipeline Entasis Therapeutics
- https://www.entasistx.com/pipeline
- Our pipeline consists of clinical and pre-clinical pathogen-targeted small-molecule antibacterials for the treatment of multidrug-resistant Gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumanii, carbapenem-resistant Enterobacteriaceae, and …
Entasis Therapeutics Holdings I (ETTX) Stock Price, News ...
- https://finance.yahoo.com/quote/ETTX/
- WALTHAM, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel ...Ask: 0.0000 x 800
SEC Filings Entasis Therapeutics Holdings Inc.
- https://investors.entasistx.com/financial-information/sec-filings
- Aug 05, 2021 · Filing date. Description. Form. View. Aug 05, 2021. Form of prospectus disclosing information facts events covered in both forms 424B1 424B3. 424B4. 0001104659-21-100806.pdf. 0001104659-21-100806.rtf.
Have you found Entasis Therapeutics Holdings Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.